![Stock Market Today: S&P500 ends above 5,500 for first time as record run continues](https://i-invdn-com.investing.com/news/LYNXMPEAA30OY_S.jpg)
Please try another search
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People’s Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Jun Xiong | 48 | 2015 | Executive Chairman |
Cong Li | 60 | 2016 | Co-CEO & Executive Director |
Jianjun Zou | 52 | 2022 | GM, CEO & Executive Director |
Yi Tang | 56 | 2015 | Non-Executive Director |
Sheng Yao | 49 | 2016 | Senior VP & Executive Director |
Zhuobing Zhang | 57 | 2016 | Deputy GM & Executive Director |
Gang Wang | 67 | 2019 | Deputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director |
Ning Li | 63 | 2018 | Executive Vice-Chairman of the Board |
Yilian Huo | 33 | 2021 | Employee Representative Supervisor |
Xiaoyuan Feng | 68 | 2021 | Independent Non-Executive Director |
Xin Li | 45 | 2023 | Executive Director |
Yu Wu | 39 | 2018 | Member of the Supervisory Board |
Anming Meng | 61 | 2023 | Independent Non-Executive Director |
Yue Yang | - | 2024 | Independent Non Executive Director |
Hongyan Kuang | - | 2024 | Chairman of the Board of Supervisors |
Chun Zhang | 67 | 2020 | Independent Non-Executive Director |
Pingping Wang | 42 | 2018 | Non-Employee Representative Supervisor |
Jingkang Shen | - | 2024 | Independent Non Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review